Edges in Network
Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
Node | F2RL1 |
Upstream (Parents) |
---|
(<<) ADAM12 → F2RL1 |
(<<) ATP2A2 → F2RL1 |
(<<) CASP3 → F2RL1 |
(<<) CDH3 → F2RL1 |
(<<) CDK8 → F2RL1 |
(<<) CHSY1 → F2RL1 |
(<<) CLCF1 → F2RL1 |
(<<) CYP1B1 → F2RL1 |
(<<) E2F6 → F2RL1 |
(<<) EGF → F2RL1 |
(<<) FZD2 → F2RL1 |
(<<) FZD3 → F2RL1 |
(<<) GNG4 → F2RL1 |
(<<) INHBA → F2RL1 |
(<<) INPPL1 → F2RL1 |
(<<) LGALS3 → F2RL1 |
(<<) LRP5 → F2RL1 |
(<<) MAP3K3 → F2RL1 |
(<<) MAP3K5 → F2RL1 |
(<<) MT1F → F2RL1 |
(<<) PLA2G6 → F2RL1 |
(<<) RPS6KA1 → F2RL1 |
(<<) SCG5 → F2RL1 |
(<<) SLC20A1 → F2RL1 |
(<<) SMAD2 → F2RL1 |
(<<) TNXB → F2RL1 |
Downstream (Children) |
---|
F2RL1 → FZD5 (>>) |
F2RL1 → GNA11 (>>) |
F2RL1 → MAP2K5 (>>) |
F2RL1 → SLC25A37 (>>) |
F2RL1 → STC2 (>>) |
F2RL1 → TAF1A (>>) |
F2RL1 → WNT5A (>>) |